IL1B and Alzheimer disease: Previous reports demonstrate that the response of the pro-inflammatory marker IL-1β is lower when a low-grade LPS challenge is repeated in a AppNL-G-F mouse model of Alzheimer’s disease, which suggest a dampening of the immune response of animals in the laboratory setting after multiple inflammatory insults63.